Siemens Healthineers AG logo

Siemens Healthineers AG

SMMNY | OTC
Chart Builder DCF Calculator
$23.83
-$0.14 (-0.58%)
At close: Oct 30, 2026, 3:59 PM ET
$23.81
-$0.02 (-0.08%)
After-hours: Oct 30, 2026, 4:00 PM ET

Company Profile

Siemens Healthineers AG (SMMNY), operating through its various subsidiaries, is a global enterprise that provides a comprehensive suite of diagnostic and therapeutic medical products and services. These offerings are extended to healthcare professionals and institutions across numerous international markets, including Germany, the United States, the broader European continent, the CIS region, Africa, the Middle East, the Americas, the Asia Pacific region, Japan, and China. The company's business is structured across four primary divisions: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment supplies cutting-edge systems such as magnetic resonance imaging (MRI), computed tomography (CT), X-ray, molecular imaging, and ultrasound technologies. It also develops sophisticated software solutions designed to streamline the interpretation and structured reporting of diagnostic images from diverse modalities. The Diagnostics segment delivers in-vitro diagnostic products and associated services, catering to healthcare providers in both general and specialized laboratory settings, as well as point-of-care diagnostics. This division further offers workflow solutions to optimize laboratory operations and provides advanced informatics products. The Varian segment specializes in oncology solutions, featuring advanced technologies like microwave, cryoablation, and embolization. It also furnishes extensive clinical professional services and tailored support programs to assist oncology departments in hospitals and clinics with their cancer care operations. The Advanced Therapies segment focuses on developing products that facilitate image-guided, minimally invasive clinical procedures. These solutions are applied across various medical specialties, including cardiology, neurology, and oncology. Its portfolio includes angiography systems, mobile C-arms, and AI-powered clinical applications that enhance procedural precision. Beyond its core product lines, Siemens Healthineers AG offers a broad range of essential technical customer services. These include maintenance and repair, provision of spare parts, medical equipment performance management, training programs, clinical education, e-learning resources, planning and design assistance, financing options, asset management, and managed departmental services for laboratories and other healthcare facilities. The company also provides healthcare consulting, products, and additional services. Established in 1896, Siemens Healthineers AG maintains its corporate headquarters in Forchheim, Germany, and functions as a subsidiary of Siemens Aktiengesellschaft.

Key Executives

Name Position
Bernhard Montag President, Chief Executive Officer & Chairman of Management Board
Jochen Schmitz Chief Financial Officer & Member of Management Board
Astrid Kristine Ploss Member of Supervisory Board, Head of Legal Advanced Therapies & Head of Legal Technology Excellence
Christian Klaussner Executive Vice President of Finance
Darleen Caron Chief Human Resources Officer, Labor Director & Member of Management Board
Elisabeth Staudinger Member of Management Board
Jerry Wang Head of China
Marc Koebernick Head of Investor Relations
Matthias Kraemer Head of Corporate Communications
Sharon J. Bracken Head of Diagnostics
Siemens Healthineers AG
Siemens Healthineers AG logo
Country Germany
IPO Date May 14, 2018
Industry Medical - Devices
Sector Healthcare
Employees 74,000
CEO Bernhard Montag

Contact Details

Siemensstr. 3 Forchheim, BV 91301 Germany

Stock Details

Ticker Symbol SMMNY
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number 82622J104
ISIN Number US82622J1043
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.